Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 78Neoplasms 69Prostatic Neoplasms 51Colorectal Neoplasms 45Lung Neoplasms 39Carcinoma, Non-Small-Cell Lung 28Hematologic Neoplasms 22Pancreatic Neoplasms 21Neoplasm Metastasis 20Head and Neck Neoplasms 20Urinary Bladder Neoplasms 15Ovarian Neoplasms 15Multiple Myeloma 15Stomach Neoplasms 11Squamous Cell Carcinoma of Head and Neck 11Motor Activity 11Leukemia, Myeloid, Acute 11Glioblastoma 10Uterine Cervical Neoplasms 9Triple Negative Breast Neoplasms 9Gastrointestinal Neoplasms 9Colonic Neoplasms 9Melanoma 8Hematopoietic and Lymphatic System Neoplasm 8Glioma 8Esophageal Neoplasms 8Carcinoma, Renal Cell 8COVID-19 8Anxiety Disorders 8Anatomic Stage I Breast Cancer AJCC v8 8

Interventions

Tobacco Use Cessation Devices 2Varenicline 1Tomography, X-Ray Computed 1Tobacco Products 1Standard of Care 1Nivolumab 1Nicotine Replacement Therapy 1Nicotine Chewing Gum 1Methods 1Gain of Function Mutation 1Cycloserine 1Counseling 1Costs and Cost Analysis 1Community Resources 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Tobacco Smoking × Standard of Care × Clear all
NCT04691297 2025-12-19

Digitally Enhanced Smoking Cessation for High Risk Smokers

Dana-Farber Cancer Institute

Phase NA Active not recruiting
153 enrolled

Tobacco Smoking, Smoking, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡